Clinical Trial Update: A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating veliparib in combination with carboplatin and paclitaxel in Japanese subjects with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Veliparib (veliparib)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED